3 Integra LifeSciences Holdings Corp. Analyst Ratings, Earnings, Dividends and Insider Trades | $IART | NASDAQ:IART | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Integra LifeSciences Holdings Corp. Company Profile (NASDAQ:IART) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Integra LifeSciences Holdings Corp. (NASDAQ:IART) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 9 Hold Rating(s), 3 Buy Rating(s)Consensus Rating:Hold (Score: 2.25)Consensus Price Target: $46.76 5.41% downside) Analysts' Ratings History for Integra LifeSciences Holdings Corp. (NASDAQ:IART) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare2/27/2014Piper JaffrayBoost Price Target$57.00 -> $59.00View 1/9/2014BarclaysBoost Price TargetEqual Weight$45.00 -> $50.00View 1/8/2014Bank of AmericaUpgradeNeutralView 1/8/2014Bank of AmericaUpgradeUnderperform -> NeutralView 11/11/2013Morgan StanleyUpgradeUnderweight -> Equal Weight$40.00View 11/3/2013Morgan StanleyReiterated RatingSell$40.00View 11/1/2013RBC CapitalBoost Price TargetSector Perform$39.00 -> $50.00View 10/29/2013Piper JaffrayBoost Price TargetOverweight$50.00 -> $57.00View 10/29/2013Jefferies GroupReiterated RatingBuy$46.00 -> $54.00View 10/23/2013Morgan StanleyDowngradeEqual Weight -> Underweight$40.00View 10/4/2013BarclaysInitiated CoverageEqual Weight$43.00View 8/22/2013Jefferies GroupBoost Price Target$43.00 -> $46.00View 8/15/2013Piper JaffrayUpgradeNeutral -> Overweight$41.00 -> $50.00View 8/2/2013OppenheimerBoost Price TargetOutperform$43.00 -> $46.00View 6/11/2013ZacksUpgradeUnderperform -> Neutral$37.80View 6/4/2013Wells Fargo & Co.Initiated CoverageMarket PerformView 5/13/2013RBC CapitalLower Price TargetSector Perform$41.00 -> $39.00View 5/6/2013Lazard Ltd.Lower Price TargetBuy$45.00 -> $41.00View 5/6/2013TheStreetDowngradeBuy -> HoldView 5/4/2013Ativo ResearchDowngradeUnfavorable -> Most UnfavorableView 4/11/2013Piper JaffrayLower Price TargetNeutral$46.00 -> $41.00View 4/11/2013Janney Montgomery ScottDowngradeBuy -> NeutralView 4/11/2013Northland SecuritiesDowngradeOutperform -> Market Perform$50.00 -> $43.00View 3/11/2013Northland SecuritiesBoost Price TargetOutperform$45.00 -> $50.00View 2/26/2013Barrington ResearchReiterated RatingOutperform$50.00View 2/25/2013Piper JaffrayBoost Price Target$43.00 -> $46.00View 2/22/2013Lazard Ltd.Lower Price Target$48.00 -> $45.00View 2/22/2013Jefferies GroupReiterated RatingBuy$43.00 -> $46.00View 1/11/2013Janney Montgomery ScottInitiated CoverageBuy$52.00View 12/27/2012JPMorgan Chase & Co.Reiterated RatingNeutralView 12/18/2012Bank of AmericaDowngradeNeutral -> UnderperformView 11/16/2012SunTrustInitiated CoverageNeutral$33.00View 10/12/2012JMP SecuritiesInitiated CoverageMarket PerformView 10/2/2012Lazard Ltd.Boost Price TargetBuy$44.00 -> $48.00View 9/10/2012OppenheimerBoost Price TargetOutperform$42.00 -> $46.00View 9/10/2012OppenheimerReiterated RatingPerformView 7/30/2012Piper JaffrayBoost Price TargetNeutral$40.00 -> $41.00View 7/27/2012Jefferies GroupBoost Price Target$40.00 -> $43.00View 6/27/2012Bank of AmericaBoost Price Target$40.00View 6/19/2012ArgusUpgradeHold -> Buy$44.00View 4/29/2012JPMorgan Chase & Co.Boost Price TargetNeutral$34.00 -> $39.00View 4/24/2012Bank of AmericaBoost Price Target$26.00 -> $36.00View (Data available from 3/11/2012 forward) Earnings History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView 10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView 8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView 5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView 2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView 10/24/2012$0.77$0.85ViewN/AView 7/26/2012$0.69$0.74ViewN/AView 4/25/2012$0.60$0.71ViewN/AView 2/23/2012$0.55$0.72ViewN/AView 10/31/2011$0.77$0.77ViewN/AView 7/28/2011$0.61$0.70ViewN/AView 4/28/2011$0.66$0.66ViewN/AView 2/24/2011$0.73$0.80ViewN/AView (Data available from 1/1/2011 forward) Dividend History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Integra LifeSciences Holdings Corp. (NASDAQ:IART)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View 2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View 2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View 2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View 1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View 1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View 1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View 1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View 8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View 8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View 8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View 8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View 8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View 7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View 5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View (Data available from 1/1/2013 forward) About Integra LifeSciences Holdings Corp. Integra LifeSciences Holdings Corporation (Integra) is an integrated medical technology company. Integra offers solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Company has developed numerous product lines for applications ranging from burn and deep tissue wounds to regeneration of dura mater in the brain and repair of nerve and tendon. It operates in five business segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. The International segment sells similar products to Europe, Middle East and Africa, and Central/South America, Asia-Pacific and Canada. On April 29, 2013, the Company launched the Integra Compact Cranial Closure System, which provides titanium implants for non-loadbearing (non-facial) operative cranial neurosurgical procedures. On April 30, 2013, it released its Hollywood VI intervertebral body fusion device (IBD) system. Headlines: (2/27) Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges (2/25) Integra LifeSciences Q4 Results Fall Short Of Estimates (2/26) Integra Lifesciences To Present At RBC Conference; Webcast At 3:05 PM ET Industry, Sector and Symbol: Sector: Healthcare Industry: Health Care Equipment & Supplies Sub-Industry: Health Care Equipment Exchange: NASDAQ Symbol: IART CUSIP: 45798520 Key Metrics: Previous Close: $49.4350 Day Moving Average: $46.7541200 Day Moving Average: $44.8048 P/E Ratio: N/AP/E Growth: 1.68Market Cap: $1.580BCurrent Quarter EPS Consensus Estimate: $3.09 EPS Additional Links: View IART on Google FinanceView IART on Yahoo FinanceView IART's Company Profile on ReutersSearch for Integra LifeSciences Holdings Corp. on Google Integra LifeSciences Holdings Corp. (NASDAQ:IART) Chart for Tuesday, March, 11, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.